Essays on the Drug Discovery Innovation System

Date

2017

Authors

Sarkissian, Alfred

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Despite the increase in scientific, monetary, and human resources devoted to drug discovery R&D, the annual number of FDA-approved drugs has been almost unchanged for decades. This study seeks clues to the R&D productivity paradox by exploring the drivers and barriers to innovation in the pharmaceutical industry. The main focus is on the contribution of science and knowledge form external sources to innovation.

Description

Keywords

Public policy, Breakthrough Innovations, Drug Discovery Innovation, Eroom’s Law, Innovation System, Orange Book, Patent Analysis

Citation